Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Expert Opinion on Therapeutic Patents
|
May 19, 2010
Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009
Sally-Ann Poulsen
Journal of the American Society for Mass Spectrometry
|
June 1, 2006
Direct screening of a dynamic combinatorial library using mass spectrometry
Sally-Ann Poulsen
Journal of Natural Products
|
June 3, 2015
Natural Product Primary Sulfonamides and Primary Sulfamates
Prashant Mujumdar, Sally-Ann Poulsen
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 11, 2014
Agents described in the Molecular Imaging and Contrast Agent Database for imaging carbonic anhydrase IX expression
Deborah Sneddon, Sally-Ann Poulsen
Molecules (Basel, Switzerland)
|
March 24, 2017
Synthesis of Novel Saccharin Derivatives
Gregory M Rankin, Sally-Ann Poulsen
Bioorganic & Medicinal Chemistry
|
January 25, 2006
Fragment-based drug discovery of carbonic anhydrase II inhibitors by dynamic combinatorial chemistry utilizing alkene cross metathesis
Sally-Ann Poulsen, Laurent F Bornaghi
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer
Kathryn F Tonissen, Sally-Ann Poulsen
Analytical Chemistry
|
December 13, 2023
Native Mass Spectrometry: Insights and Opportunities for Targeted Protein Degradation
Louise M Sternicki, Sally-Ann Poulsen
RSC Medicinal Chemistry
|
August 6, 2025
Toward routine utilisation of native mass spectrometry as an enabler of contemporary drug development
Louise M Sternicki, Sally-Ann Poulsen
RSC Medicinal Chemistry
|
July 19, 2024
Fragment-based drug discovery campaigns guided by native mass spectrometry
Louise M Sternicki, Sally-Ann Poulsen
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Expert Opinion on Therapeutic Patents
|
May 19, 2010
Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009
Sally-Ann Poulsen
Journal of the American Society for Mass Spectrometry
|
June 1, 2006
Direct screening of a dynamic combinatorial library using mass spectrometry
Sally-Ann Poulsen
Journal of Natural Products
|
June 3, 2015
Natural Product Primary Sulfonamides and Primary Sulfamates
Prashant Mujumdar, Sally-Ann Poulsen
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 11, 2014
Agents described in the Molecular Imaging and Contrast Agent Database for imaging carbonic anhydrase IX expression
Deborah Sneddon, Sally-Ann Poulsen
Molecules (Basel, Switzerland)
|
March 24, 2017
Synthesis of Novel Saccharin Derivatives
Gregory M Rankin, Sally-Ann Poulsen
Bioorganic & Medicinal Chemistry
|
January 25, 2006
Fragment-based drug discovery of carbonic anhydrase II inhibitors by dynamic combinatorial chemistry utilizing alkene cross metathesis
Sally-Ann Poulsen, Laurent F Bornaghi
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer
Kathryn F Tonissen, Sally-Ann Poulsen
Analytical Chemistry
|
December 13, 2023
Native Mass Spectrometry: Insights and Opportunities for Targeted Protein Degradation
Louise M Sternicki, Sally-Ann Poulsen
RSC Medicinal Chemistry
|
August 6, 2025
Toward routine utilisation of native mass spectrometry as an enabler of contemporary drug development
Louise M Sternicki, Sally-Ann Poulsen
RSC Medicinal Chemistry
|
July 19, 2024
Fragment-based drug discovery campaigns guided by native mass spectrometry
Louise M Sternicki, Sally-Ann Poulsen
Page
of 9